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scan was interpreted as positive, if there was presence of a suspicious 
mass as noted by radiologists. 
Results: 107 patients were identiﬁed form the PET center database, of 
which 74 patients had at least one positive paraneoplastic antibody. 
PET was positive in total of 48 patients, 32 of which had antibody 
positive PNS. Malignancy was detected in 10 patients, of which 9 had a 
positive PET. There was 1 case of malignancy (fallopian tube adeno-
carcinoma) with negative PET report .2 patients with positive PET 
deferred biopsy. CT scan was able to identify only 3 of the 10 malig-
nancies detected. Malignancies diagnosed were small cell carcinomas 
(N=4), mixed small and large cell (N=1), adenocarcinoma of the lung 
(N=1), adenocarcinoma of unknown origin (N=1) and thymoma (N=1). 
Of patients with antibody positive PNS, PET scan had a positive pre-
dictive value and negative predictive value of 28% and 97%, respec-
tively. The diagnostic accuracy of PET scan was calculated to be 67%.
Conclusion: PET is a useful diagnostic tool in the evaluation of anti-
body positive PNS patients when standard imaging is non diagnostic.
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Introduction: Lung cancer remains the leading cause of cancer death 
in men.Skeletal scintigraphy is exquisitely sensitive to the remodel-
ing process and is typically abnormal months before or more prior to 
the appearance of radiographic changes in lung cancer patients.The 
characteristic scintigraphic appearance is intense uptake at the site of 
metastases and fracture site.Finding bone metastases is frequently im-
portant to clinical decisions affecting quality of life.Detection of such 
bone metastatic lesions before comlications allows radiation therapy or 
surgical intervenations to prevent pathologic fractures from disabling 
the patients of lung cancer.It also helps in the staging of the disease.We 
have investigated 47 patients of different types of Cancer refered by 
surgeons,radiotherapists and chemotherapists. 
Adsorption of 99mTc-MDP occurs on to the mineral phase of the bone.
The uptake is signiﬁcantly higher in amorphous calcium phosphate 
than in mature crystalline hydroxyappatite.This explain the avidity of 
tracer for areas of increased osteogenic activity.High sensitivity of bone 
scanning in determining the presence and extent of metastatic disease 
makes extremely important tool in decision making. Bone scans dem-
onstrate metastatic lesions much earlier than X-ray, C.T., MRI. 
Skeletal radiopharmaceutical Tc99m-MDP distributed rapidly through-
out the extracellular space.Uptake in bone is also rapid,clearance is via 
the kidneys.
Materials and Methods: A total of 47 patients,all males,in the range 
of 45 to 82 years old was investigated before and after surgery, radiothe
rapy,chemotherapy and during followup. 22 to 25 mCi 0f Tc99m-MDP 
was injected IV, static Ant. and posterior views of entire skeleton was 
taken under the gamma camera.
Results: Total 47 patients was investigated.
On visual analysis there was positive scan ﬁndings (bone mets) in 18 
patients (38.29%) and negative scan ﬁndings (normal bone scan) in 29 
patients (61.71%). 
8/47 pts(17.02%) were cases of lung cancer.
4/47 pts( 8.51%)were diagnosed as lung cancer with bone metastasis. 
(One case was diagnosed as Lung cancer with pathological fracture and 
multiple bone mets).
Discussion: Signiﬁcance of bone mets is in the management of lung 
cancer when clinically and radiographically stage I and scintigraphi-
cally stage IV,here change of treatment is needed.Bone sacn are very 
sensitive for detecting the altered local metabolism in areas of skeletal 
remodeling associated with metastatic deposits. Sensitivity for detect-
ing bone mets is quoted as 95% or above.
Conclusions: Non-Invasive and a very sensitive and speciﬁc method.
Bone scan is Mendatory in lung cancer patient’s before and after Sur-
gery, Radiotherapy and Chemotherapy,and during followup, with very 
low radiation.Results are very encourasing.
Quality of life will be good,If diagnosed early, accurately and Managed 
properly.
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Background: The main indication to re-mediastinoscopy is to control 
neoadjuvant therapy response in patients with advanced lung cancer 
(Stage III A-B). The decision on surgical treatment necessity is based 
on downstaged cancer. But re-mediastinoscopy not always results in 
proper staging and some patients are not treated accordingly. 
Materials and Methods: From January 1995 to December 2006, 45 
patients with N2-3 disease NSCLC underwent re-mediastinoscopy 
to assess neoadjuvant therapy beneﬁts. There were 38 males and 8 
females. Mean age was 65 years. Squamous cancer was in 31 case, 
adenocarcinoma in 14. At primary mediastinoscopy N2 disease was in 
40 (88%), N3 disease - in 5(12%). Time interval between primary and 
redo mediastinoscopy was from 48 to 87 days, during this period two 
courses of platinum based chemotherapy was administered. 
Results: . Re-mediastinoscopy and restaging was performed in all 
cases. Downstaging was in 17 cases (37%), the unchanged stage was 
in 19 (42%), cancer progression - 9 (20%) - they were referred to ra-
diotherapy. The rest 36 patients underwent systematic lymph node dis-
section and bilateral systematic lymph node dissection via transsternal 
approach. Among operated on patients cancer progression was found in 
8 (22%). Among operated on patients with progression 3-year survival 
rate was 25% and in patients with radiotherapy - 0%.
Conclusions: Re-mediastinoscopy allows to exclude from an opera-
tional list patients with cancer progression. In about 25% patients 
restaging showed wrong results. With sufﬁcient cardio-respiratory 
reserves pulmonary resection with systematic lymph node dissection 
advantages proper restaging, and diagnosis with correct results at rea-
sonable postoperative mortality and morbidity rates. 
